Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
44 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07065344 | A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region(DOMAIN) | recruiting | — | 500 | AstraZenecaINDUSTRY | 10 | Sep 23, 2026 | clinicaltrials |
| NCT04543617 | A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy(SKYSCRAPER-07) | completed | Phase 3 | 760 | Hoffmann-La Roche |
| 28 |
| Sep 14, 2026 |
| clinicaltrials |
| NCT07650773 | CHARM Hepatocellular Carcinoma MEA Study | recruiting | — | 4,000 | AstraZenecaINDUSTRY | 7 | Sep 3, 2026 | clinicaltrials |
| NCT07723365 | Epidemiological, Clinicopathological, and Surgical Characteristics of Eyelid Carcinomas(epidemiology) | completed | — | 20 | Mohammed VI University HospitalOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT07670234 | Dietary Supplements Among Cancer Patients: Tolerance, Impact on Medications, and Potential Drug Interactions(Dietary Supple) | recruiting | — | 1,000 | Centre Mohammed VI de la Recherche et de l'Innovation (CM6RI)OTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT07367074 | Effect of an Educational Intervention in Women With Breast Cancer (EDU-INT-BC)(EDU-INT-BC) | completed | N/A | 62 | Instituts Supérieurs des Professions Infirmières et Techniques de Santé, MoroccoOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT03371017 | A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer(IMpassion132) | completed | Phase 3 | 595 | Hoffmann-La RocheINDUSTRY | 28 | Nov 12, 2025 | clinicaltrials |
| NCT03285763 | A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)(TAIL) | completed | Phase 4 | 619 | Hoffmann-La RocheINDUSTRY | 24 | Jan 23, 2025 | clinicaltrials |
| NCT06292988 | Predictive Factors for Medullary Thyroid Cancer Aggressiveness(MYELO) | completed | — | 500 | Aristotle University Of ThessalonikiOTHER | 24 | Jan 3, 2025 | clinicaltrials |
| NCT02406092 | Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A | completed | Phase 3 | 139 | Hoffmann-La RocheINDUSTRY | 3 | Nov 21, 2024 | clinicaltrials |
| NCT03140176 | Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.(OPTIMISE) | terminated | — | 77 | PfizerINDUSTRY | 4 | May 10, 2024 | clinicaltrials |
| NCT03125902 | A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)(IMpassion131) | completed | Phase 3 | 653 | Hoffmann-La RocheINDUSTRY | 24 | Mar 26, 2024 | clinicaltrials |
| NCT03447132 | Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant(SAFIA) | completed | Phase 3 | 354 | International Cancer Research Group, United Arab EmiratesOTHER | 8 | Mar 10, 2023 | clinicaltrials |
| NCT05494281 | Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer(USB22) | unknown | N/A | 94 | Moroccan Society of SurgeryOTHER | 1 | Sep 22, 2022 | clinicaltrials |
| NCT05453318 | Efficacy and Acceptability of Thermal Ablation in the Treatment of Cervical Neoplasia | completed | N/A | 119 | International Agency for Research on CancerOTHER | 1 | Jul 12, 2022 | clinicaltrials |
| NCT04133324 | C-protein Reactive for the Detection of Anastomotic Leakage After Surgery for Digestive Cancer | unknown | — | 500 | Moroccan Society of SurgeryOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT03681600 | Observatory of the Quality of Surgical Procedures for Digestive Cancers(Obchir) | terminated | — | 1,043 | Moroccan Society of SurgeryOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT04676438 | Persistant Post-mastectomy Pain in Breast Cancer : Incidence and Risk Factors | completed | — | 722 | Moroccan Society of SurgeryOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT01566721 | A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer(SafeHER) | completed | Phase 3 | 2,577 | Hoffmann-La RocheINDUSTRY | 59 | Apr 27, 2021 | clinicaltrials |
| NCT00793390 | Case-Control Study of Inflammatory Breast Cancer in North Africa | completed | — | 815 | National Cancer Institute (NCI)NIH | 3 | Dec 24, 2020 | clinicaltrials |
| NCT01572038 | A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer(PERUSE) | completed | Phase 3 | 1,436 | Hoffmann-La RocheINDUSTRY | 39 | Sep 25, 2020 | clinicaltrials |
| NCT04141566 | Pseudo Continent Perineal Colostomy vs Permanent Left Iliac Colostomy After Abdominoperineal Resection for Ultra Low Rectal Adenocarcinoma | completed | — | 35 | Moroccan Society of SurgeryOTHER | 1 | Sep 1, 2020 | clinicaltrials |
| NCT04349384 | Audit of Surgery for Colorectal Cancer(AuditCR) | completed | — | 136 | Institut National d'Oncologie, MoroccoOTHER_GOV | 1 | Apr 16, 2020 | clinicaltrials |
| NCT03176238 | Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer(EVEREXES) | completed | Phase 3 | 235 | Novartis PharmaceuticalsINDUSTRY | 13 | Apr 7, 2020 | clinicaltrials |
| NCT04128657 | Validation of the Moroccan Arabic Version of the Low Anterior Resection Syndrome (LARS) and Wexner Score of Continence Among Rectal Cancer Patients(MA_LARSWEX) | completed | — | 143 | Moroccan Society of SurgeryOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT04248634 | Evaluation of Delayed Coloanal Anastomosis(ACAD) | completed | — | 20 | Institut National d'Oncologie, MoroccoOTHER_GOV | 1 | Feb 20, 2020 | clinicaltrials |
| NCT04000802 | Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers | completed | — | 200 | Moroccan Society of SurgeryOTHER | 1 | Oct 17, 2019 | clinicaltrials |
| NCT02304406 | Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa(ALK NSCLC MENA) | completed | — | 449 | PfizerINDUSTRY | 5 | Jul 19, 2019 | clinicaltrials |
| NCT00828386 | Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers(NPC2006) | terminated | Phase 3 | 83 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 4 | Jan 18, 2019 | clinicaltrials |
| NCT03601689 | Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma | completed | — | 84 | Moroccan Society of SurgeryOTHER | 2 | Jul 26, 2018 | clinicaltrials |
| NCT00722137 | Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma | completed | Phase 3 | 487 | Millennium Pharmaceuticals, Inc.INDUSTRY | 29 | Jul 12, 2018 | clinicaltrials |
| NCT00439426 | A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. | completed | Phase 2 | 25 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00293540 | Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer | completed | Phase 3 | 249 | International Breast Cancer Research FoundationOTHER | 10 | Jul 27, 2016 | clinicaltrials |
| NCT00565448 | Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents | completed | Phase 2 | 75 | SanofiINDUSTRY | 14 | Jul 30, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT00201851 | Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer | completed | Phase 3 | 740 | International Breast Cancer Research FoundationOTHER | 3 | Apr 29, 2015 | clinicaltrials |
| NCT01991340 | H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast Cancer | completed | — | 657 | Hoffmann-La RocheINDUSTRY | 2 | Nov 25, 2013 | clinicaltrials |
| NCT00864331 | Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy | completed | Phase 3 | 251 | International Atomic Energy AgencyOTHER_GOV | 13 | Aug 7, 2013 | clinicaltrials |
| NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 3 | 3,300 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 29 | Mar 28, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT01452672 | Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer | unknown | Phase 3 | 600 | International Atomic Energy AgencyOTHER_GOV | 8 | Oct 17, 2011 | clinicaltrials |
| NCT00122772 | CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy | completed | Phase 3 | 601 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 14, 2011 | clinicaltrials |
| NCT00916097 | NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT) | completed | Phase 2 | 66 | SanofiINDUSTRY | 3 | Jun 24, 2009 | clinicaltrials |
Data updated 4 days agoSource updated unknownsource: clinicaltrials